JPRN-UMIN000023490已完成未知
The Safety and Efficacy of 5-Aminolevulinic Acid (ALA) Therapy for Sideroblastic Anemia - The Safety and Efficacy of 5-Aminolevulinic Acid (ALA) Therapy for Sideroblastic Anemia
Department of Hematolgy and Rheumatology, Tohoku University Graduate School of Medicine0 个研究点目标入组 5 人开始时间: 2016年8月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Thrombocytopenia (less than 100,000), neutropenia (less than 1,500) 2)Patients who do not understand the study. 3) Serious complication (renal insufficiency with Ccr < 30 ml/min, liver insufficiency with total bilirubin >2 mg/dL, hypoxia requiring home oxygen therapy)
研究者
相似试验
尚未招募
2 期
To know the Safe and Effect of 5-aminolevulinic acid hydrochloride and Sodium Ferrous Citrate combination drug on Malaria Patients to treat malaria.CTRI/2018/09/015824eopharma Japan Co Ltd
进行中（未招募）
1 期
5-Aminolevulinic acid (5-ALA) in children and adolescents with differnt types of brain tumoursintra-axial brain tumor (malignant glioma, astrocytoma, malignant ependymoma, AT/RT, Oligodendroglioma, etc.)MedDRA version: 20.0Level: LLTClassification code 10006154Term: Brain tumor NOSSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2014-005669-54-DEniversität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Personal und Recht80
尚未招募
2 期
Clinical safety study on 5-Aminolevulinic acid (5-ALA) in children and adolescents with supratentorial brain tumorsbrain tumorsSupratentorial10029211NL-OMON52327Westfälische Wilhelms-Universität Münster10
进行中（未招募）
1 期
5-Aminolevulinic acid (5-ALA) in children and adolescents with different types of brain tumoursEUCTR2014-005669-54-NLWestfälische Wilhelms-Universität Münster c/o Universitätsklinikum Münster, Geschäftsbereich Recht u. Drittmittel80
招募中
2 期
Effects of 5-aminolevulinic acid on the quality of life in patients with glioblastomaGlioblastoma multiforme.Malignant neoplasm of brain, unspecifiedC71.9IRCT20140810018745N12Tehran University of Medical Sciences40